L774-0213 Screening compound: 3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl)propan-1-one

L774-0213 Screening compound: 3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl)propan-1-one
L774-0213 Screening compound: 3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L774-0213
3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L774-0213

Molecular Formula

C26H31N3O3 (C26 H31 N3 O3)

Compound Name

3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl)propan-1-one

IUPAC name

3-(4-methoxyphenyl)-1-(1-methyl-3-{[(2-methylphenyl)methoxy]methyl}-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl)propan-1-one

SMILES

Cc1c(COCc2nn(C)c(CC3)c2CN3C(CCc(cc2)ccc2OC)=O)cccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.881

Distribution Coefficient, logD

3.881

Water Solubility, LogSw

-4.06

Polar Surface Area

47.241

Acid Dissociation Constant (pKa)

22.39

Base Dissociation Constant (pKb)

9.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

L774-0213 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L774-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L774-0213?
Check Price and Availability of L774-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L774-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L774-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L774-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L774-0213 available by request